• News
  • Film and TV
  • Music
  • Tech
  • Features
  • Celebrity
  • Politics
  • Weird
  • Community
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
YouTube
Submit Your Content
Scientists explain why magic mushrooms can combat Parkinson's disease

Home> News> Health

Published 15:02 1 May 2025 GMT+1

Scientists explain why magic mushrooms can combat Parkinson's disease

The first-of-its-kind study made a ground-breaking revelation

Ellie Kemp

Ellie Kemp

When I hear the words 'magic mushrooms,' I imagine a group of indie-looking teenagers micro-dosing at a festival.

An estimated eight million American adults used psilocybin in 2023, according to figures from RAND.

Whether it's used to enhance some sort of guided meditation, or to experience some life-changing epiphanies in the park with your friends one sunny day, it's been proven the psychedelic drug - called psilocybin - can help with anxiety and depression.

Advert

However, researchers from the University of California San Francisco (UCSF) have seen some incredible results after trialing the drug with Parkinson's disease patients.

The condition mainly affects people over the age of 50 and occurs when parts of the brain become progressively damaged over time.

Its symptoms include involuntary shaking or tremors, muscle stiffness and anxiety and depression.

Parkinson's affects almost one million Americans (Alexey Koza/Getty Images)
Parkinson's affects almost one million Americans (Alexey Koza/Getty Images)

Advert

The study is the first of its kind to test the effects of psychedelics on patients with a neurodegenerative disease.

Parkinson's is the second-most common neurodegenerative disease after Alzheimer's. Nearly one million people in the US are living with the condition, the Parkinson's Foundation reports - a figure that's expected to rise to 1.2 million in the next five years.

The groundbreaking pilot study, saw 12 patients with 'mild to moderate' Parkinson’s receive two doses of psilocybin: 10 mg, followed by 25 mg two weeks later.

They also underwent regular psychotherapy sessions to track their wellbeing.

Advert

The study’s aim was to assess the safety of psilocybin, yet the results uncovered something unexpected - and pretty incredible.

The psilocybin study is the first of its kind (Microgen Images/Science Photo Library/Getty Images)
The psilocybin study is the first of its kind (Microgen Images/Science Photo Library/Getty Images)

Participants experienced significant, lasting improvements in mood, cognition and motor function, which persisted for weeks after the drug had left their systems. These mental health improvements were reported for up to three months after their final dose of the drug. Scientists reckon this could be chalked up to two major reasons.

Firstly, psilocybin's impact on patient's mood could've led to better cognitive and motor functions.

Advert

This, in turn, would've helped them socialize and become more active - both key elements of Parkinson’s treatment.

Another is that psilocybin could reduce inflammation and promote neuroplasticity, which is the growth and reconnection of brain cells involved in mood, cognition, and movement regulation.

It's thought psilocybin could've helped Parkinson's patients socialize more, thus improving their mood (Morsa Images/Getty Images)
It's thought psilocybin could've helped Parkinson's patients socialize more, thus improving their mood (Morsa Images/Getty Images)

“We are still in very early stages of this work, but this first study went well beyond what we expected,” said the paper’s first author, Ellen Bradley, MD, assistant professor and associate director of UCSF’s Translational Psychedelic Research Program (TrPR).

Advert

“Many people don’t realize this, but mood symptoms in Parkinson’s are linked to a faster physical decline,” she said. “And they are actually a stronger predictor of patients’ quality of life with Parkinson's than their motor symptoms.”

Encouraged by the results, UCSF is set to launch a larger, randomized trial in partnership with Yale, aiming to enrol 100 participants.

This next phase will incorporate brain imaging and other tools to understand psilocybin’s effects on brain function in more detail.

“The vast majority of brain diseases lack treatments that change their course,” said Dr. Joshua Woolley, senior author. “These results raise the exciting possibility that psilocybin may help the brain repair itself.”

Featured Image Credit: Cannabis-Pic/Getty Images

Topics: Mental Health, Drugs

Ellie Kemp
Ellie Kemp

Advert

Advert

Advert

Choose your content:

6 hours ago
7 hours ago
  • 6 hours ago

    Experts issue urgent warning against popular new tanning 'drug' that could cause brain swelling and cancer

    The viral trend promises to give users a natural glowing tan

    News
  • 7 hours ago

    Horrifying details emerge after plane carrying 200 passengers flies with no pilot after first officer collapsed

    The plane was diverted and thankfully all 200 passengers onboard landed safely.

    News
  • 7 hours ago

    Family win $100,000 in settlement after being accused of not paying $200 bill

    Peter and Ann McGirr were slammed in a Facebook post which falsely claimed they hadn't paid their bill

    News
  • 7 hours ago

    Chilling story of man who told family he was leaving with aliens and hasn't been seen since

    What happened to Granger Taylor has remained a mystery for 45 years

    News
  • NASA scientists explain why astronauts strap down their arms to avoid 'zombie pose'
  • Symptoms of kidney disease explained as scientists discover surprising way to detect the illness
  • Woman who replaced coffee with mushrooms for 10 days reveals the impact it had on her daily life
  • Former Alaska Airlines pilot who allegedly tried to shut off plane’s engines while high on psychedelic mushrooms speaks out